Amicrobe, Inc.
Synthetic biological polymers for therapeutics and medical devices
- Sector
- Biotech
- Headquarters
- CARLSBAD, CA
- Founded
- 2010
- Latest Form D
- $5M, Apr 2024
- Total capital
- $22.7M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $22.7M
- 3 Form D · last Apr 2024
- 30 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 7
- 8 pending · first 2015
- Rank in peer group#213 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$5M
- Private capital raisedForm D · SEC · 2nd filing$16.7M
- Private capital raisedForm D · SEC · 1st filing$1.0M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#213 · top 15%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Michael BevilacquaResearcherExecutive Officer, DirectorLinked by 7 patents
- Albert CarnesaleDirectorNamed in SEC Form D filings
- Daniel HuangExecutive OfficerNamed in SEC Form D filings
- Joseph BoystakExecutive Officer, DirectorNamed in SEC Form D filings
- Martin BurnsDirectorNamed in SEC Form D filings
- Michael FleschExecutive Officer, DirectorNamed in SEC Form D filings
Show all 7 people
- Scott HayashiExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 7 granted of 15- PendingCompositions And Uses Of Locally-applied Antimicrobial Synthetic Cationic Polypeptide(s) With Enhanced Performance And SafetyUSPTOApplication 19090034
- PendingCompositions And Uses Of Antimicrobial Materials With Tissue-compatible PropertiesUSPTOApplication 18749392
- GrantedCompositions And Uses Of Locally-applied Antimicrobial Synthetic Cationic Polypeptide(s) With Enhanced Performance And SafetyUSPTOUS 12,268,722
Show all 15 patent records
- Compositions And Uses Of Locally-applied Antimicrobial Synthetic Cationic Polypeptide(s) With Enhanced Performance And SafetyFeb 12, 2026 · Application 19090034Pending
- Compositions And Uses Of Antimicrobial Materials With Tissue-compatible PropertiesApr 17, 2025 · Application 18749392Pending
- Compositions And Uses Of Locally-applied Antimicrobial Synthetic Cationic Polypeptide(s) With Enhanced Performance And SafetyApr 8, 2025 · US 12,268,722Granted
- Compositions And Uses Of Antimicrobial Materials With Tissue-compatible PropertiesJun 25, 2024 · US 12,016,898Granted
- Compositions And Uses Of Locally Applied Synthetic Amino Acid Polymers For Prevention And Treatment Of Viral InfectionsMay 18, 2023 · Application 17917858Pending
- Compositions And Uses Of Antimicrobial Materials With Tissue-compatible PropertiesApr 12, 2022 · US 11,298,401Granted
- Compositions And Uses Of Locally-applied Antimicrobial Synthetic Cationic Polypeptide(s) With Enhanced Performance And SafetyMar 29, 2022 · US 11,285,189Granted
- Composition With High Antimicrobial Activity And Low ToxicitySep 17, 2020 · Application 16658861Pending
- Composition With High Antimicrobial Activity And Low ToxicityOct 22, 2019 · US 10,448,634Granted
- Compositions And Uses Of Antimicrobial Materials With Tissue-compatible PropertiesSep 20, 2016 · US 9,446,090Granted
- Compositions And Uses Of Materials With High Antimicrobial Activity And Low ToxicityApr 28, 2015 · US 9,017,730Granted
- Compositions And Uses Of Locally Applied Synthetic Amino Acid Polymers For Prevention And Treatment Of Viral InfectionsApplication PCTUS2021025925Pending
- Compositions And Uses Of Locally Applied Antimicrobials With Enhanced Performance And SafetyApplication PCTUS2018026322Pending
- Compositions And Uses Of Antimicrobial Materials With Tissue-compatible PropertiesApplication PCTUS2013032535Pending
- Compositions And Uses Of Materials With High Antimicrobial Activity And Low ToxicityApplication PCTUS2011048869Pending
Related companies, and why
- Reprogram Biosciences, Inc.Similar federal contract value in Biotech · null in contracts
- Cynaptec Pharmaceuticals, Inc.Similar federal contract value in Biotech · null in contracts
- Replicate Bioscience, Inc.Similar federal contract value in Biotech · null in contracts
- NurExone Biologic Inc.Similar federal contract value in Biotech · null in contracts
- Beta Cat Pharmaceuticals, Inc.Similar federal contract value in Biotech · null in contracts
- Outpost Medicine, LLCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .